Difficulty: Medium
Average Score: 87%
Testbank
The nurse provides care to a menopausal client who states, 'I read a news article that says I am at risk for coronary vascular disease due to inflammation.' Which method should the nurse suggest to the client to aid in the prevention of inflammation that can lead to atherosclerosis?
Correct answer
A
Rationale
Addressing obesity is essential for preventing inflammation that can lead to atherosclerosis in menopausal clients. Excess body weight is linked to increased inflammatory markers, which can contribute to the development of coronary vascular disease. By promoting weight loss and maintaining a healthy weight, the client can reduce inflammation and lower the risk of atherosclerosis.
B: Avoiding the use of caffeine does not significantly impact inflammation related to atherosclerosis. While some studies suggest caffeine may have inflammatory effects, the evidence is not strong enough to warrant it as a primary preventive measure for coronary vascular disease.
C: Taking a daily multivitamin may provide some general health benefits, but it does not directly address inflammation or obesity, which are more critical factors in preventing atherosclerosis in menopausal women.
D: Drinking at least 2 liters of water a day is important for overall hydration and health, but it does not specifically target obesity or inflammation, which are key contributors to coronary vascular disease risk.
B: Avoiding the use of caffeine does not significantly impact inflammation related to atherosclerosis. While some studies suggest caffeine may have inflammatory effects, the evidence is not strong enough to warrant it as a primary preventive measure for coronary vascular disease.
C: Taking a daily multivitamin may provide some general health benefits, but it does not directly address inflammation or obesity, which are more critical factors in preventing atherosclerosis in menopausal women.
D: Drinking at least 2 liters of water a day is important for overall hydration and health, but it does not specifically target obesity or inflammation, which are key contributors to coronary vascular disease risk.